Financials
- Market Capitalization 22.94 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.41
ratio cours/chiffre d'affaires
3.86
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 519 | ROIV Roivant Sciences Ltd. - Common Shares | 35.00 USD | +1.42% | -2.40% | +16.43% | +91.15% | 25.17 B USD | ||
| 537 | INSM Insmed Incorporated - Common Stock | 109.29 USD | +0.14% | -3.27% | +10.68% | -32.56% | 23.69 B USD | ||
| 564 | UTHR United Therapeutics Corporation - Common Stock | 526.03 USD | -1.78% | -6.07% | -3.65% | +76.70% | 22.33 B USD | ||
| 572 | BNTX BioNTech SE - American Depositary Shares | 91.15 USD | +1.20% | -3.40% | -0.07% | -17.88% | 21.87 B USD |